Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The bleeding patient

S J Machin

    British Journal of Hospital Medicine
    |August 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    This study discusses acquired hemostatic defects, emphasizing prompt replacement therapy with plasma, coagulation factors, and platelets. Effective patient management combines clinical assessment with laboratory data interpretation for flexible treatment policies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A performance evaluation of a novel human recombinant tissue factor prothrombin time reagent (Revohem<sup>™</sup> PT).

    International journal of laboratory hematology·2017
    Same author

    ICSH recommendations for modified and alternate methods measuring the erythrocyte sedimentation rate.

    International journal of laboratory hematology·2017
    Same author

    Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism.

    Journal of thrombosis and haemostasis : JTH·2016
    Same author

    Recombinant Alpha 2A Interferon-An Effective Maintenance Agent in Essential Thrombocythaemia.

    Leukemia & lymphoma·2016
    Same author

    Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome.

    Journal of thrombosis and haemostasis : JTH·2015
    Same author

    ICSH recommendations for the standardization of nomenclature and grading of peripheral blood cell morphological features.

    International journal of laboratory hematology·2015
    Same journal

    The autopsy in the 1990s.

    British journal of hospital medicine·1999
    Same journal

    Screening for breast cancer.

    British journal of hospital medicine·1999
    Same journal

    Cost-effective monotherapy of concomitant benign prostatic hyperplasia and hypertension.

    British journal of hospital medicine·1999
    Same journal

    Liposarcoma: a review of current diagnosis and management.

    British journal of hospital medicine·1999
    Same journal

    How to do it in surgery: laparoscopic rectopexy.

    British journal of hospital medicine·1999
    Same journal

    The management of ovarian cancer.

    British journal of hospital medicine·1999
    See all related articles

    Area of Science:

    • Hematology
    • Clinical Pathology

    Background:

    • Acquired hemostatic defects are common clinical challenges.
    • Routine laboratory investigations are crucial for diagnosing hemostatic abnormalities.

    Purpose of the Study:

    • To review frequently encountered acquired hemostatic defects.
    • To outline essential laboratory investigations and their clinical significance.
    • To emphasize prompt and effective replacement therapy for bleeding patients.

    Main Methods:

    • Review of acquired hemostatic defects.
    • Discussion of routine laboratory investigations.
    • Analysis of clinical significance of laboratory findings.

    Main Results:

    • Identification of common acquired hemostatic defects.

    Related Experiment Videos

  • Correlation of laboratory results with clinical presentation.
  • Importance of timely intervention with plasma, coagulation factors, and platelet infusions.
  • Conclusions:

    • A combined approach of clinical assessment and laboratory data interpretation is vital.
    • Prompt and assessed replacement therapy ensures effective management of bleeding patients.
    • Flexible treatment policies should be adopted based on individual patient needs.